DE69634543D1 - Thiol-derivative mit metallopeptidase hemmender wirkung - Google Patents

Thiol-derivative mit metallopeptidase hemmender wirkung

Info

Publication number
DE69634543D1
DE69634543D1 DE69634543T DE69634543T DE69634543D1 DE 69634543 D1 DE69634543 D1 DE 69634543D1 DE 69634543 T DE69634543 T DE 69634543T DE 69634543 T DE69634543 T DE 69634543T DE 69634543 D1 DE69634543 D1 DE 69634543D1
Authority
DE
Germany
Prior art keywords
hemdering
opeptidase
thiol
derivatives
metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69634543T
Other languages
English (en)
Inventor
Franco Pellacini
Mario Fantucci
Gabriele Norcini
Stefano Romagnano
Francesco Santangelo
Claudio Semeraro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Application granted granted Critical
Publication of DE69634543D1 publication Critical patent/DE69634543D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Treatment Of Fiber Materials (AREA)
  • Preliminary Treatment Of Fibers (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69634543T 1995-12-28 1996-12-17 Thiol-derivative mit metallopeptidase hemmender wirkung Expired - Lifetime DE69634543D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI002773A IT1277737B1 (it) 1995-12-28 1995-12-28 Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
PCT/EP1996/005663 WO1997024342A1 (en) 1995-12-28 1996-12-17 Thiol derivatives with metallopeptidase inhibitory activity

Publications (1)

Publication Number Publication Date
DE69634543D1 true DE69634543D1 (de) 2005-05-04

Family

ID=11372827

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69634543T Expired - Lifetime DE69634543D1 (de) 1995-12-28 1996-12-17 Thiol-derivative mit metallopeptidase hemmender wirkung

Country Status (31)

Country Link
EP (1) EP0877740B1 (de)
JP (1) JP2000502687A (de)
KR (1) KR19990076809A (de)
CN (1) CN1071325C (de)
AP (1) AP1186A (de)
AR (1) AR004413A1 (de)
AT (1) ATE292123T1 (de)
AU (1) AU713156B2 (de)
BG (1) BG63942B1 (de)
BR (1) BR9612373A (de)
CA (1) CA2241414A1 (de)
CZ (1) CZ204698A3 (de)
DE (1) DE69634543D1 (de)
EA (1) EA000991B1 (de)
EE (1) EE03766B1 (de)
GE (1) GEP19991871B (de)
HK (1) HK1018008A1 (de)
IL (1) IL124915A (de)
IS (1) IS1885B (de)
IT (1) IT1277737B1 (de)
NO (1) NO310914B1 (de)
NZ (1) NZ325785A (de)
OA (1) OA10704A (de)
PL (1) PL188151B1 (de)
RO (1) RO119882B1 (de)
SK (1) SK282977B6 (de)
TR (1) TR199801229T2 (de)
UA (1) UA62923C2 (de)
UY (1) UY24425A1 (de)
WO (1) WO1997024342A1 (de)
ZA (1) ZA9610891B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1289522B1 (it) * 1996-12-24 1998-10-15 Zambon Spa Processo per la preparazione di eteroaril-fenilalanine
MY153569A (en) 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
GB0203665D0 (en) * 2002-02-15 2002-04-03 Glaxo Group Ltd Process
MY140707A (en) 2002-02-28 2010-01-15 Mitsubishi Tanabe Pharma Corp Process for preparing a phenylalanine derivative and intermediates thereof
EP1481967B1 (de) 2002-03-05 2011-05-04 Sumitomo Chemical Company, Limited Verfahren zur herstellung von biarylverbindungen
TW200407310A (en) * 2002-06-07 2004-05-16 Glaxo Group Ltd Compounds
GB0213122D0 (en) * 2002-06-07 2002-07-17 Glaxo Group Ltd Compounds
US7045653B2 (en) 2002-12-23 2006-05-16 Pfizer, Inc. Pharmaceuticals
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
US20080161321A1 (en) 2004-03-17 2008-07-03 David Louis Feldman Use of Renin Inhibitors in Therapy
EP2414625B1 (de) 2009-04-03 2014-05-07 Statoil Petroleum AS Einrichtung und verfahren zur verstärkung einer bohrung eines bohrlochs beim bohren
CN102811989A (zh) 2010-02-03 2012-12-05 Meh联合公司 作为具有选择性和生物活性的等排物的多取代氟甲烷
TW201136582A (en) 2010-03-16 2011-11-01 Novartis Ag Improved pharmaceutical compositions of aliskiren and methods of delivery

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401677A (en) * 1981-10-09 1983-08-30 E. R. Squibb & Sons, Inc. Enkephalinase inhibitors
FR2652087B1 (fr) * 1989-09-15 1993-10-15 Bioprojet Ste Civile Derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques.
FR2682952B1 (fr) * 1991-10-25 1993-12-03 Institut Nal Sante Recherc Medic Nouveaux n-(mercaptoacyl) amino-acides, leur preparation et les compositions pharmaceutiques qui les contiennent.
IT1273455B (it) * 1995-01-27 1997-07-08 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi

Also Published As

Publication number Publication date
AP9801264A0 (en) 1998-06-30
PL327580A1 (en) 1998-12-21
NZ325785A (en) 1999-09-29
AP1186A (en) 2003-07-07
KR19990076809A (ko) 1999-10-15
SK88998A3 (en) 1998-12-02
EE03766B1 (et) 2002-06-17
JP2000502687A (ja) 2000-03-07
CA2241414A1 (en) 1997-07-10
AR004413A1 (es) 1998-11-04
IL124915A (en) 2001-10-31
RO119882B1 (ro) 2005-05-30
EP0877740A1 (de) 1998-11-18
HK1018008A1 (en) 1999-12-10
GEP19991871B (en) 1999-12-06
BR9612373A (pt) 1999-07-13
AU713156B2 (en) 1999-11-25
PL188151B1 (pl) 2004-12-31
EP0877740B1 (de) 2005-03-30
ATE292123T1 (de) 2005-04-15
IS4780A (is) 1998-06-22
CN1071325C (zh) 2001-09-19
EA199800544A1 (ru) 1999-02-25
ZA9610891B (en) 1997-06-27
SK282977B6 (sk) 2003-01-09
CZ204698A3 (cs) 1998-11-11
OA10704A (en) 2002-11-28
ITMI952773A1 (it) 1997-06-28
NO982977D0 (no) 1998-06-26
WO1997024342A1 (en) 1997-07-10
AU1301897A (en) 1997-07-28
IS1885B (is) 2003-08-15
ITMI952773A0 (de) 1995-12-28
NO310914B1 (no) 2001-09-17
IL124915A0 (en) 1999-01-26
EA000991B1 (ru) 2000-08-28
CN1206411A (zh) 1999-01-27
IT1277737B1 (it) 1997-11-12
BG102553A (en) 1999-04-30
NO982977L (no) 1998-08-27
BG63942B1 (bg) 2003-07-31
EE9800192A (et) 1998-12-15
TR199801229T2 (xx) 1998-09-21
UA62923C2 (en) 2004-01-15
UY24425A1 (es) 1997-01-09

Similar Documents

Publication Publication Date Title
NO962362L (no) Grensaks
FI951018A0 (fi) Hoeghastighetsdataoeverfoering i mobiltelesystem
DE59609887D1 (de) Substituierte cyanophenyluracile
DE69529982T2 (de) Bakteriozin
DE69634543D1 (de) Thiol-derivative mit metallopeptidase hemmender wirkung
DE59610332D1 (de) Substituierte aminouracile
BR9611723A (pt) Bifenil éter-oxazolinas
BR9608890A (pt) N-metilenotiouréias substituídas
BR9609319A (pt) Carbonilaminofeniluracilas substituídas
DE69604385D1 (de) Isocumarine mit antitumorwirkung
DE29508283U1 (de) Durchlauftrockner
BR9603376A (pt) Tetrahidro-5-nitro-pirimidinas substituídas
DE59607732D1 (de) Substituierte benzylidencyanessigester
DE59607958D1 (de) Substituierte phenyluracile
KR970011833U (ko) 세절기
DE29514813U1 (de) Baumschere
KR950013571U (ko) 세절기
SE9503081D0 (sv) Gjutformelement
FI955522A0 (fi) Formelement
KR970015790U (ko) 잔디블럭
FI954924A0 (fi) Syntetiska smoerjmedelsbasoljor
DE29504283U1 (de) Baumschere
BR7500363U (pt) Formulário
ITDP940011A0 (it) Tandem agricolato
KR960030077U (ko) 농산물 건조기

Legal Events

Date Code Title Description
8332 No legal effect for de